<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36613462</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>20</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">15</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24010015</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) is characterized by a broad spectrum of clinical symptoms. After acute infection, some subjects develop a post-COVID-19 syndrome known as long-COVID. This study aims to recognize the molecular and functional mechanisms that occur in COVID-19 and long-COVID patients and identify useful biomarkers for the management of patients with COVID-19 and long-COVID. Here, we profiled the response to COVID-19 by performing a proteomic analysis of lymphocytes isolated from patients. We identified significant changes in proteins involved in iron metabolism using different biochemical analyses, considering ceruloplasmin (Cp), transferrin (Tf), hemopexin (HPX), lipocalin 2 (LCN2), and superoxide dismutase 1 (SOD1). Moreover, our results show an activation of 5-lipoxygenase (5-LOX) in COVID-19 and in long-COVID possibly through an iron-dependent post-translational mechanism. Furthermore, this work defines leukotriene B4 (LTB4) and lipocalin 2 (LCN2) as possible markers of COVID-19 and long-COVID and suggests novel opportunities for prevention and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dufrusine</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7515-9794</Identifier><AffiliationInfo><Affiliation>Department of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentinuzzi</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bibb&#xf2;</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6007-9222</Identifier><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damiani</LastName><ForeName>Verena</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-2833-841X</Identifier><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lanuti</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4197-9780</Identifier><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Aging Science, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieragostino</LastName><ForeName>Damiana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1015-3484</Identifier><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Boccio</LastName><ForeName>Piero</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1653-2194</Identifier><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alessandro</LastName><ForeName>Ersilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabottini</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berghella</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1743-6404</Identifier><AffiliationInfo><Affiliation>Department of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allocati</LastName><ForeName>Nerino</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2670-8085</Identifier><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falasca</LastName><ForeName>Katia</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8795-5410</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Aging Science, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Infectious Diseases, S.S. Annunziata Hospital, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ucciferri</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5866-3849</Identifier><AffiliationInfo><Affiliation>Clinic of Infectious Diseases, S.S. Annunziata Hospital, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mucedola</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinic of Infectious Diseases, S.S. Annunziata Hospital, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Perna</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pneumology Department, "SS Annunziata" Hospital, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Pneumology Department, "SS Annunziata" Hospital, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vecchiet</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine and Aging Science, "G. d'Annunzio" University of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic of Infectious Diseases, S.S. Annunziata Hospital, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Laurenzi</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Innovative Technologies in Medicine and Dentistry, University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio" of Chieti-Pescara, 66100 Chieti, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dainese</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7163-9344</Identifier><AffiliationInfo><Affiliation>Department of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FISR2020IP_03845</GrantID><Agency>Italian Ministry of University and Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071068">Lipocalin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.11.34</RegistryNumber><NameOfSubstance UI="D001094">Arachidonate 5-Lipoxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="Y">Iron</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071068" MajorTopicYN="N">Lipocalin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001094" MajorTopicYN="N">Arachidonate 5-Lipoxygenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">5-lipoxygenase</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">iron metabolism</Keyword><Keyword MajorTopicYN="N">leukotriene B4</Keyword><Keyword MajorTopicYN="N">lipocalin 2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36613462</ArticleId><ArticleId IdType="pmc">PMC9819889</ArticleId><ArticleId IdType="doi">10.3390/ijms24010015</ArticleId><ArticleId IdType="pii">ijms24010015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation (WHO) COVID-19 Weekly Epidemiological Update. WHO; Geneva, Switzerland: 2022. pp. 1&#x2013;26.</Citation></Reference><Reference><Citation>Caramaschi S., Kapp M.E., Miller S.E., Eisenberg R., Johnson J., Epperly G., Maiorana A., Silvestri G., Giannico G.A. Histopathological Findings and Clinicopathologic Correlation in COVID-19: A Systematic Review. Mod. Pathol. 2021;34:1614&#x2013;1633. doi: 10.1038/s41379-021-00814-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00814-w</ArticleId><ArticleId IdType="pmc">PMC8141548</ArticleId><ArticleId IdType="pubmed">34031537</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo P., Falasca K., Ucciferri C., Sinjari B., Aruffo E., Antonucci I., Di Serafino A., Pompilio A., Damiani V., Mandatori D., et al. Normal Breathing Releases SARS-CoV-2 into the Air. J. Med. Microbiol. 2021;70:001328. doi: 10.1099/jmm.0.001328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001328</ArticleId><ArticleId IdType="pmc">PMC8346733</ArticleId><ArticleId IdType="pubmed">33629949</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyerowitz E.A., Richterman A., Gandhi R.T., Sax P.E. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann. Intern. Med. 2021;174:69&#x2013;79. doi: 10.7326/M20-5008.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5008</ArticleId><ArticleId IdType="pmc">PMC7505025</ArticleId><ArticleId IdType="pubmed">32941052</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi R.T., Lynch J.B., del Rio C. Mild or Moderate COVID-19. N. Engl. J. Med. 2020;383:1757&#x2013;1766. doi: 10.1056/NEJMcp2009249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X., Deng Y., Dai Z., Meng Z. COVID-19 and Anosmia: A Review Based on up-to-Date Knowledge. Am. J. Otolaryngol. 2020;41:102581. doi: 10.1016/j.amjoto.2020.102581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102581</ArticleId><ArticleId IdType="pmc">PMC7265845</ArticleId><ArticleId IdType="pubmed">32563019</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Salzano G., Deiana G., De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope. 2020;130:1787. doi: 10.1002/lary.28692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.28692</ArticleId><ArticleId IdType="pmc">PMC7228304</ArticleId><ArticleId IdType="pubmed">32237238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo P., Xing Y., Xiao Y., Deng L., Zhao Q., Wang H., Xiong Y., Cheng Z., Gao S., Liang K., et al. Clinical Characteristics of Refractory COVID-19 Pneumonia in Wuhan, China. Clin. Infect. Dis. 2020;73:e4208&#x2013;e4213. doi: 10.1093/cid/ciaa270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa270</ArticleId><ArticleId IdType="pmc">PMC7184444</ArticleId><ArticleId IdType="pubmed">32173725</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer N.J., Gattinoni L., Calfee C.S. Acute Respiratory Distress Syndrome. Lancet. 2021;398:622&#x2013;637. doi: 10.1016/S0140-6736(21)00439-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00439-6</ArticleId><ArticleId IdType="pmc">PMC8248927</ArticleId><ArticleId IdType="pubmed">34217425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorman E.A., O&#x2019;Kane C.M., McAuley D.F. Acute Respiratory Distress Syndrome in Adults: Diagnosis, Outcomes, Long-Term Sequelae, and Management. Lancet. 2022;400:1157&#x2013;1170. doi: 10.1016/S0140-6736(22)01439-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01439-8</ArticleId><ArticleId IdType="pubmed">36070788</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:3&#x2013;9. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the Long Term Effects of COVID-19: Summary of NICE, SIGN, and RCGP Rapid Guideline. BMJ. 2021;372:10&#x2013;13. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazato Y., Morioka S., Tsuzuki S., Akashi M., Osanai Y., Tanaka K., Terada M., Suzuki M., Kutsuna S., Saito S., et al. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect. Dis. 2020;7:4&#x2013;6. doi: 10.1093/ofid/ofaa507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa507</ArticleId><ArticleId IdType="pmc">PMC7665672</ArticleId><ArticleId IdType="pubmed">33230486</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of Post-Acute COVID-19 in Primary Care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine. 2021;38:2&#x2013;19. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID&#x2014;Mechanisms, Risk Factors, and Management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., et al. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B., Wang C., Tan Y., Chen X., Liu Y., Ning L., Chen L., Li M., Liu Y., Wang G., et al. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19) Front. Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00827</ArticleId><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohiuddin Chowdhury A.T.M., Karim M.R., Ali M.A., Islam J., Li Y., He S. Clinical Characteristics and the Long-Term Post-Recovery Manifestations of the COVID-19 Patients&#x2014;A Prospective Multicenter Cross-Sectional Study. Front. Med. 2021;8:66367. doi: 10.3389/fmed.2021.663670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.663670</ArticleId><ArticleId IdType="pmc">PMC8416537</ArticleId><ArticleId IdType="pubmed">34490284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan Ali O., Bomze D., Risch L., Brugger S.D., Paprotny M., Weber M., Thiel S., Kern L., Albrich W.C., Kohler P., et al. Severe Coronavirus Disease 2019 (COVID-19) Is Associated with Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin. Infect. Dis. 2021;73:E2869&#x2013;E2874. doi: 10.1093/cid/ciaa1496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1496</ArticleId><ArticleId IdType="pmc">PMC7543315</ArticleId><ArticleId IdType="pubmed">32997739</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidepriem J., Dahlke C., Kobbe R., Santer R., Koch T., Fathi A., Seco B.M.S., Ly M.L., Schmiedel S., Schwinge D., et al. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with Elisa, Peptide, and Glycan Arrays: An Immunological Case Series. Pathogens. 2021;10:438. doi: 10.3390/pathogens10040438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10040438</ArticleId><ArticleId IdType="pmc">PMC8067489</ArticleId><ArticleId IdType="pubmed">33917609</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J., Sandmann S., Ochs K., Schrempf I.M., Fr&#xf6;mmel C., Dugas M., Schmidt H.H., Vollenberg R., Tepasse P.R. Persistent Symptoms and Lab Abnormalities in Patients Who Recovered from COVID-19. Sci. Rep. 2021;11:12775. doi: 10.1038/s41598-021-91270-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91270-8</ArticleId><ArticleId IdType="pmc">PMC8211641</ArticleId><ArticleId IdType="pubmed">34140539</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A.A., Kamath K., et al. Distinguishing Features of Long COVID Identified through Immune Profiling. medRxiv. 2022:1&#x2013;13. doi: 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Amiri-Dashatan N., Koushki M., Parsamanesh N., Chiti H. Serum Cortisol Concentration and COVID-19 Severity: A Systematic Review and Meta-Analysis. J. Investig. Med. 2022;70:766&#x2013;772. doi: 10.1136/jim-2021-001989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-001989</ArticleId><ArticleId IdType="pubmed">35058334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramezani M., Simani L., Karimialavijeh E., Rezaei O., Hajiesmaeili M., Pakdaman H. Anxiety and Cortisol in Outcomes of Patients With COVID-19. Basic Clin. Neurosci. J. 2020;11:179&#x2013;184. doi: 10.32598/bcn.11.covid19.1168.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.32598/bcn.11.covid19.1168.2</ArticleId><ArticleId IdType="pmc">PMC7368100</ArticleId><ArticleId IdType="pubmed">32855777</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe W.E., Maglova L.M., Ponka P., Russell J.M. Human Cytomegalovirus-Induced Host Cell Enlargement Is Iron Dependent. Am. J. Physiol. Cell Physiol. 2004;287:1023&#x2013;1030. doi: 10.1152/ajpcell.00511.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00511.2003</ArticleId><ArticleId IdType="pubmed">15175225</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakesmith H., Prentice A. Viral Infection and Iron Metabolism. Nat. Rev. Microbiol. 2008;6:541&#x2013;552. doi: 10.1038/nrmicro1930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1930</ArticleId><ArticleId IdType="pubmed">18552864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganz T. Systemic Iron Homeostasis. Physiol. Rev. 2013;93:1721&#x2013;1741. doi: 10.1152/physrev.00008.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00008.2013</ArticleId><ArticleId IdType="pubmed">24137020</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdan A.R., Miyazawa M., Hashimoto K., Tsuji Y. Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease. Trends Biochem. Sci. 2016;41:274&#x2013;286. doi: 10.1016/j.tibs.2015.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2015.11.012</ArticleId><ArticleId IdType="pmc">PMC4783254</ArticleId><ArticleId IdType="pubmed">26725301</ArticleId></ArticleIdList></Reference><Reference><Citation>Des R., Richardson P.P. The Molecular Mechanisms of Iron and Ferritin Metabolism in Normal and Neoplastic Cells. Philosophy. 1996;1331:1&#x2013;40. doi: 10.1016/s0304-4157(96)00014-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-4157(96)00014-7</ArticleId><ArticleId IdType="pubmed">9325434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward D.M., Kaplan J. Ferroportin-Mediated Iron Transport: Expression and Regulation. Biochim. Biophys. Acta-Mol. Cell Res. 2012;1823:1426&#x2013;1433. doi: 10.1016/j.bbamcr.2012.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2012.03.004</ArticleId><ArticleId IdType="pmc">PMC3718258</ArticleId><ArticleId IdType="pubmed">22440327</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y., Ren Z., Gao S., Shen J., Wang L., Xu Z., Yu Y., Bachina P., Zhang H., Fan X., et al. Structural Basis of Ion Transport and Inhibition in Ferroportin. Nat. Commun. 2020;11:5686. doi: 10.1038/s41467-020-19458-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19458-6</ArticleId><ArticleId IdType="pmc">PMC7655804</ArticleId><ArticleId IdType="pubmed">33173040</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaschella C., Nai A., Silvestri L. Iron Metabolism and Iron Disorders Revisited in the Hepcidin Era. Haematologica. 2020;105:260&#x2013;272. doi: 10.3324/haematol.2019.232124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2019.232124</ArticleId><ArticleId IdType="pmc">PMC7012465</ArticleId><ArticleId IdType="pubmed">31949017</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter W.E., Bazydlo L.A.L., Harris N.S. The Molecular Biology of Human Iron Metabolism. Lab. Med. 2014;45:92&#x2013;102. doi: 10.1309/LMF28S2GIMXNWHMM.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/LMF28S2GIMXNWHMM</ArticleId><ArticleId IdType="pubmed">24868988</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakesmith H., Prentice A.M. Hepcidin and the Iron-Infection Axis. Science. 2012;338:768&#x2013;772. doi: 10.1126/science.1224577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1224577</ArticleId><ArticleId IdType="pubmed">23139325</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacht E.R., Davis W.B. Role of Transferrin and Ceruloplasmin in Antioxidant Activity of Lung Epithelial Lining Fluid. J. Appl. Physiol. 1988;64:2092&#x2013;2099. doi: 10.1152/jappl.1988.64.5.2092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1988.64.5.2092</ArticleId><ArticleId IdType="pubmed">3391908</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponka P., Lok C.N. The Transferrin Receptor: Role in Health and Disease. Int. J. Biochem. Cell Biol. 1999;31:1111&#x2013;1137. doi: 10.1016/S1357-2725(99)00070-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1357-2725(99)00070-9</ArticleId><ArticleId IdType="pubmed">10582342</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels T.R., Delgado T., Rodriguez J.A., Helguera G., Penichet M.L. The Transferrin Receptor Part I: Biology and Targeting with Cytotoxic Antibodies for the Treatment of Cancer. Clin. Immunol. 2006;121:144&#x2013;158. doi: 10.1016/j.clim.2006.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2006.06.010</ArticleId><ArticleId IdType="pubmed">16904380</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X., Yeoh B.S., Vijay-Kumar M. Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation. Annu. Rev. Nutr. 2017;37:103&#x2013;130. doi: 10.1146/annurev-nutr-071816-064559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-nutr-071816-064559</ArticleId><ArticleId IdType="pubmed">28628361</ArticleId></ArticleIdList></Reference><Reference><Citation>Devireddy L.R., Gazin C., Zhu X., Green M.R. A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake. Cell. 2005;123:1293&#x2013;1305. doi: 10.1016/j.cell.2005.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.10.027</ArticleId><ArticleId IdType="pubmed">16377569</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes M.A., Paulsene W., Jide X., Ratledge C., Strong R.K. Siderocalin (Lcn 2) Also Binds Carboxymycobactins, Potentially Defending against Mycobacterial Infections through Iron Sequestration. Structure. 2005;13:29&#x2013;41. doi: 10.1016/j.str.2004.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2004.10.009</ArticleId><ArticleId IdType="pubmed">15642259</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A., McCulloh R.J. Hemopexin and Haptoglobin: Allies against Heme Toxicity from Hemoglobin Not Contenders. Front. Physiol. 2015;6:187. doi: 10.3389/fphys.2015.00187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2015.00187</ArticleId><ArticleId IdType="pmc">PMC4485156</ArticleId><ArticleId IdType="pubmed">26175690</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskew J.D., Vanacore R.M., Sung L.M., Morales P.J., Smith A. Cellular Protection Mechanisms against Extracellular Heme: Heme- Hemopexin, but Not Free Heme, Activates the N-Terminal c-Jun Kinase. J. Biol. Chem. 1999;274:638&#x2013;648. doi: 10.1074/jbc.274.2.638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.2.638</ArticleId><ArticleId IdType="pubmed">9872997</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada Y., Miyamoto T., Kashima H., Kobara H., Asaka R., Ando H., Higuchi S., Ida K., Shiozawa T. Lipocalin 2 Attenuates Iron-Related Oxidative Stress and Prolongs the Survival of Ovarian Clear Cell Carcinoma Cells by up-Regulating the CD44 Variant. Free Radic. Res. 2016;50:414&#x2013;425. doi: 10.3109/10715762.2015.1134795.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2015.1134795</ArticleId><ArticleId IdType="pubmed">26729415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ighodaro O.M., Akinloye O.A. First Line Defence Antioxidants-Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid. Alexandria J. Med. 2018;54:287&#x2013;293. doi: 10.1016/j.ajme.2017.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajme.2017.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt P.J., Toran P.T., Giannetti A.M., Bjorkman P.J., Andrews N.C. The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression. Cell Metab. 2008;7:205&#x2013;214. doi: 10.1016/j.cmet.2007.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2007.11.016</ArticleId><ArticleId IdType="pmc">PMC2292811</ArticleId><ArticleId IdType="pubmed">18316026</ArticleId></ArticleIdList></Reference><Reference><Citation>Thursz M. Iron, Haemochromatosis and Thalassaemia as Risk Factors for Fibrosis in Hepatitis C Virus Infection. Gut. 2007;56:613&#x2013;614. doi: 10.1136/gut.2006.113076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.2006.113076</ArticleId><ArticleId IdType="pmc">PMC1942141</ArticleId><ArticleId IdType="pubmed">17440181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang M.L., Hu J.H., Yen C.H., Chen K.H., Kuo C.J., Lin M.S., Lee C.H., Chen S.C., Chien R.N. Evolution of Ferritin Levels in Hepatitis C Patients Treated with Antivirals. Sci. Rep. 2020;10:19744. doi: 10.1038/s41598-020-76871-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76871-z</ArticleId><ArticleId IdType="pmc">PMC7661708</ArticleId><ArticleId IdType="pubmed">33184464</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider B.A., Spiegelman D., Hertzmark E., Sando D., Duggan C., Makubi A., Sudfeld C., Aris E., Chalamilla G.E., Fawzi W.W. Anemia, Iron Deficiency, and Iron Supplementation in Relation to Mortality among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Tanzania. Am. J. Trop. Med. Hyg. 2019;100:1512&#x2013;1520. doi: 10.4269/ajtmh.18-0096.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.18-0096</ArticleId><ArticleId IdType="pmc">PMC6553903</ArticleId><ArticleId IdType="pubmed">31017077</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagliola D.G., De Montalembert M., Lefrere J.J., Briand C., Rebulla P., Baruchel S., Dessi C., Fondu P., Karagiorga M., Perrimond H. Dose of Desferrioxamine and Evolution of HIV-1 Infection in Thalassaemic Patients. Br. J. Haematol. 1994;87:849&#x2013;852. doi: 10.1111/j.1365-2141.1994.tb06750.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.1994.tb06750.x</ArticleId><ArticleId IdType="pubmed">7986727</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou N.A., Van Der Bruggen T., Oudshoorn M., Nottet H.S.L.M., Marx J.J.M., van Asbeck B.S. Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Mononuclear Blood Cells by the Iron Chelators Deferoxamine, Deferiprone, and Bleomycin. J. Infect. Dis. 2000;181:484&#x2013;490. doi: 10.1086/315223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315223</ArticleId><ArticleId IdType="pubmed">10669330</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwamaka M., Kurtis J.D., Sorensen B.E., Holte S., Morrison R., Mutabingwa T.K., Fried M., Duffy P.E. Iron Deficiency Protects against Severe Plasmodium Falciparum Malaria and Death in Young Children. Clin. Infect. Dis. 2012;54:1137&#x2013;1144. doi: 10.1093/cid/cis010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis010</ArticleId><ArticleId IdType="pmc">PMC3309886</ArticleId><ArticleId IdType="pubmed">22354919</ArticleId></ArticleIdList></Reference><Reference><Citation>Spottiswoode N., Duffy P.E., Drakesmith H. Iron, Anemia and Hepcidin in Malaria. Front. Pharmacol. 2014;5:125. doi: 10.3389/fphar.2014.00125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2014.00125</ArticleId><ArticleId IdType="pmc">PMC4039013</ArticleId><ArticleId IdType="pubmed">24910614</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassat J.E., Skaar E.P. Iron in Infection and Immunity. Cell Host Microbe. 2013;13:509&#x2013;519. doi: 10.1016/j.chom.2013.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.04.010</ArticleId><ArticleId IdType="pmc">PMC3676888</ArticleId><ArticleId IdType="pubmed">23684303</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufrusine B., Di Francesco A., Oddi S., Scipioni L., Angelucci C.B., D&#x2019;Addario C., Serafini M., H&#xe4;fner A.K., Steinhilber D., Maccarrone M., et al. Iron-Dependent Trafficking of 5-Lipoxygenase and Impact on Human Macrophage Activation. Front. Immunol. 2019;10:01347. doi: 10.3389/fimmu.2019.01347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01347</ArticleId><ArticleId IdType="pmc">PMC6610208</ArticleId><ArticleId IdType="pubmed">31316498</ArticleId></ArticleIdList></Reference><Reference><Citation>Torti S.V., Torti F.M. Iron and Cancer: More Ore to Be Mined. Nat. Rev. Cancer. 2013;13:342&#x2013;355. doi: 10.1038/nrc3495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3495</ArticleId><ArticleId IdType="pmc">PMC4036554</ArticleId><ArticleId IdType="pubmed">23594855</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Yu L., Ding J., Chen Y. Iron Metabolism in Cancer. Int. J. Mol. Sci. 2019;20:95. doi: 10.3390/ijms20010095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010095</ArticleId><ArticleId IdType="pmc">PMC6337236</ArticleId><ArticleId IdType="pubmed">30591630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N., Alghory A., Kiyak Z., Alwani A., Seida R. Ferritin&#x2014;from Iron, through Inflammation and Autoimmunity, to COVID-19. J. Autoimmun. 2020;126:102778. doi: 10.1016/j.jaut.2021.102778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102778</ArticleId><ArticleId IdType="pmc">PMC8647584</ArticleId><ArticleId IdType="pubmed">34883281</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss G., Ganz T., Goodnough L.T. Anemia of in Fl Ammation. Blood. 2019;133:40&#x2013;50. doi: 10.1182/blood-2018-06-856500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-06-856500</ArticleId><ArticleId IdType="pmc">PMC6536698</ArticleId><ArticleId IdType="pubmed">30401705</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikseresht S., Bush A.I., Ayton S. Treating Alzheimer&#x2019;s Disease by Targeting Iron. Br. J. Pharmacol. 2019;176:3622&#x2013;3635. doi: 10.1111/bph.14567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.14567</ArticleId><ArticleId IdType="pmc">PMC6715619</ArticleId><ArticleId IdType="pubmed">30632143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong N.J., Dibb R., Bulk M., van der Weerd L., Liu C. Imaging Beta Amyloid Aggregation and Iron Accumulation in Alzheimer&#x2019;s Disease Using Quantitative Susceptibility Mapping MRI. Neuroimage. 2019;191:176&#x2013;185. doi: 10.1016/j.neuroimage.2019.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2019.02.019</ArticleId><ArticleId IdType="pubmed">30739060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Wang Y.H., Chen K.H., Chen C.H., Wang C.Y. The Clinical Efficacy and Safety of Anti-Viral Agents for Non-Hospitalized Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Viruses. 2022;14:1706. doi: 10.3390/v14081706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081706</ArticleId><ArticleId IdType="pmc">PMC9415971</ArticleId><ArticleId IdType="pubmed">36016328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ucciferri C., Barone M., Vecchiet J., Falasca K. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients. Mediterr. J. Hematol. Infect. Dis. 2020;12:11&#x2013;13. doi: 10.4084/mjhid.2020.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/mjhid.2020.048</ArticleId><ArticleId IdType="pmc">PMC7340237</ArticleId><ArticleId IdType="pubmed">32670526</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;ardes D., Pontolillo M., Esposito L., Masciarelli M., Boccatonda A., Rossi I., Bucci M., Guagnano M.T., Ucciferri C., Santilli F., et al. Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms. 2020;8:1327. doi: 10.3390/microorganisms8091327.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8091327</ArticleId><ArticleId IdType="pmc">PMC7564504</ArticleId><ArticleId IdType="pubmed">32878286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ucciferri C., Vecchiet J., Falsca K. Role of monoclonal antibody drugs in the treatment of COVID-19. World J. Clin. Cases. 2020;8:4280&#x2013;4285. doi: 10.12998/wjcc.v8.i19.4280.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v8.i19.4280</ArticleId><ArticleId IdType="pmc">PMC7559676</ArticleId><ArticleId IdType="pubmed">33083387</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. 2021.  [(accessed on 23 December 2021)].  Available online:  https://WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1.</Citation></Reference><Reference><Citation>Rushton D.H., Barth J.H. What Is the Evidence for Gender Differences in Ferritin and Haemoglobin? Crit. Rev. Oncol. Hematol. 2010;73:1&#x2013;9. doi: 10.1016/j.critrevonc.2009.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.critrevonc.2009.03.010</ArticleId><ArticleId IdType="pubmed">19394859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., Scarabelli T.M., Chen-Scarabelli C., Saravolatz L., Dioguardi F.S. Serum Metabolic Profile in Patients with Long-COVID (PASC) Syndrome: Clinical Implications. Front. Med. 2021;8:714426. doi: 10.3389/fmed.2021.714426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Faul F., Erdfelder E., Lang A.-G., Buchner A. G*Power 3: A Flexible Statistical Power Analysis Program for the Social, Behavioral, and Biomedical Sciences. Behav. Res. Methods. 2007;39:175&#x2013;191. doi: 10.3758/BF03193146.</Citation><ArticleIdList><ArticleId IdType="doi">10.3758/BF03193146</ArticleId><ArticleId IdType="pubmed">17695343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecca L., Youdim M.B.H., Riederer P., Connor J.R., Crichton R.R. Iron, Brain Ageing and Neurodegenerative Disorders. Nat. Rev. Neurosci. 2004;5:863&#x2013;873. doi: 10.1038/nrn1537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1537</ArticleId><ArticleId IdType="pubmed">15496864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M.K., Kim R.Y., Brown A.C., Donovan C., Vanka K.S., Mayall J.R., Liu G., Pillar A.L., Jones-Freeman B., Xenaki D., et al. Critical Role for Iron Accumulation in the Pathogenesis of Fibrotic Lung Disease. J. Pathol. 2020;251:49&#x2013;62. doi: 10.1002/path.5401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5401</ArticleId><ArticleId IdType="pubmed">32083318</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., Zhang H., Chang J., Li D., Cao P. Iron Overload and Mitochondrial Dysfunction Orchestrate Pulmonary Fibrosis. Eur. J. Pharmacol. 2021;912:174613. doi: 10.1016/j.ejphar.2021.174613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.174613</ArticleId><ArticleId IdType="pubmed">34740581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Chen P., Zhai B., Zhang M., Xiang Y., Fang J., Xu S., Gao Y., Chen X., Sui X., et al. The Emerging Role of Ferroptosis in Inflammation. Biomed. Pharmacother. 2020;127:110108. doi: 10.1016/j.biopha.2020.110108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110108</ArticleId><ArticleId IdType="pubmed">32234642</ArticleId></ArticleIdList></Reference><Reference><Citation>Regenboog M., van Kuilenburg A.B.P., Verheij J., Swinkels D.W., Hollak C.E.M. Hyperferritinemia and Iron Metabolism in Gaucher Disease: Potential Pathophysiological Implications. Blood Rev. 2016;30:431&#x2013;437. doi: 10.1016/j.blre.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2016.05.003</ArticleId><ArticleId IdType="pubmed">27265538</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaschella C., Poggiali E. Towards Explaining &#x201c;Unexplained Hyperferrltlnemla&#x201d;. Haematologica. 2009;94:307&#x2013;309. doi: 10.3324/haematol.2008.005405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2008.005405</ArticleId><ArticleId IdType="pmc">PMC2649347</ArticleId><ArticleId IdType="pubmed">19252171</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulert G.S., Canna S.W. Convergent Pathways of the Hyperferritinemic Syndromes. Int. Immunol. 2018;30:195&#x2013;203. doi: 10.1093/intimm/dxy012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxy012</ArticleId><ArticleId IdType="pmc">PMC7189979</ArticleId><ArticleId IdType="pubmed">29420734</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros&#xe1;rio C., Zandman-Goddard G., Meyron-Holtz E.G., D&#x2019;Cruz D.P., Shoenfeld Y. The Hyperferritinemic Syndrome: Macrophage Activation Syndrome, Still&#x2019;s Disease, Septic Shock and Catastrophic Antiphospholipid Syndrome. BMC Med. 2013;11:185&#x2013;197. doi: 10.1186/1741-7015-11-185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-185</ArticleId><ArticleId IdType="pmc">PMC3751883</ArticleId><ArticleId IdType="pubmed">23968282</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W., Knovich M.A., Coffman L., Torti F., Torti S.V. Serum Ferritin: Past, Present and Future Wei. Bone. 2011;23:760&#x2013;769. doi: 10.1016/j.bbagen.2010.03.011.Serum.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2010.03.011.Serum</ArticleId><ArticleId IdType="pmc">PMC2893236</ArticleId><ArticleId IdType="pubmed">20304033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalueza A., Ayuso B., Arrieta E., Trujillo H., Folgueira D., Cueto C., Serrano A., Laureiro J., Ar&#xe9;valo-Ca&#xf1;as C., Castillo C., et al. Elevation of Serum Ferritin Levels for Predicting a Poor Outcome in Hospitalized Patients with Influenza Infection. Clin. Microbiol. Infect. 2020;26:1557.e9&#x2013;1557.e15. doi: 10.1016/j.cmi.2020.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.02.018</ArticleId><ArticleId IdType="pubmed">32120038</ArticleId></ArticleIdList></Reference><Reference><Citation>Barut S., Dincer F., Sahin I., Ozyurt H., Akkus M., Erkorkmaz U. Increased Serum Ferritin Levels in Patients with Crimean-Congo Hemorrhagic Fever: Can It Be a New Severity Criterion? Int. J. Infect. Dis. 2010;14:50&#x2013;54. doi: 10.1016/j.ijid.2009.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2009.03.009</ArticleId><ArticleId IdType="pubmed">19487150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression. Lancet. 2020;395:1033&#x2013;1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Colafrancesco S., Alessandri C., Conti F., Priori R. COVID-19 Gone Bad: A New Character in the Spectrum of the Hyperferritinemic Syndrome? Autoimmun. Rev. 2020;19:102573&#x2013;102578. doi: 10.1016/j.autrev.2020.102573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102573</ArticleId><ArticleId IdType="pmc">PMC7199723</ArticleId><ArticleId IdType="pubmed">32387470</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone C., Bartoloni E., Bursi R., Cafaro G., Guidelli G.M., Shoenfeld Y., Gerli R. COVID-19 as Part of the Hyperferritinemic Syndromes: The Role of Iron Depletion Therapy. Immunol. Res. 2020;68:213&#x2013;224. doi: 10.1007/s12026-020-09145-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-020-09145-5</ArticleId><ArticleId IdType="pmc">PMC7366458</ArticleId><ArticleId IdType="pubmed">32681497</ArticleId></ArticleIdList></Reference><Reference><Citation>Suriawinata E., Mehta K.J. Iron and Iron-Related Proteins in COVID-19. Clin. Exp. Med. 2022:1&#x2013;23. doi: 10.1007/s10238-022-00851-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00851-y</ArticleId><ArticleId IdType="pmc">PMC9289930</ArticleId><ArticleId IdType="pubmed">35849261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Boehm A., Sahanic S., Pizzini A., Aichner M., Sonnweber B., Kurz K., Koppelst&#xe4;tter S., Haschka D., Petzer V., et al. Persisting Alterations of Iron Homeostasis in COVID-19 Are Associated with Non-Resolving Lung Pathologies and Poor Patients&#x2019; Performance: A Prospective Observational Cohort Study. Respir. Res. 2020;21:276&#x2013;285. doi: 10.1186/s12931-020-01546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01546-2</ArticleId><ArticleId IdType="pmc">PMC7575703</ArticleId><ArticleId IdType="pubmed">33087116</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib H.M., Ibrahim S., Zaim A., Ibrahim W.H. The Role of Iron in the Pathogenesis of COVID-19 and Possible Treatment with Lactoferrin and Other Iron Chelators. Biomed. Pharmacother. 2021;136:111228&#x2013;111238. doi: 10.1016/j.biopha.2021.111228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111228</ArticleId><ArticleId IdType="pmc">PMC7836924</ArticleId><ArticleId IdType="pubmed">33454595</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.J., Sugiyama M., Shimokawa F., Murakami M., Hashimoto O., Matsui T., Funaba M. Response to Iron Overload in Cultured Hepatocytes. Sci. Rep. 2020;10:21184. doi: 10.1038/s41598-020-78026-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78026-6</ArticleId><ArticleId IdType="pmc">PMC7713074</ArticleId><ArticleId IdType="pubmed">33273573</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg M.F., Goldberg M.F., Cerejo R., Tayal A.H. Cerebrovascular Disease in COVID-19. Am. J. Neuroradiol. 2020;41:1170&#x2013;1172. doi: 10.3174/ajnr.A6588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6588</ArticleId><ArticleId IdType="pmc">PMC7357639</ArticleId><ArticleId IdType="pubmed">32409316</ArticleId></ArticleIdList></Reference><Reference><Citation>Edeas M., Saleh J., Peyssonnaux C. Iron: Innocent Bystander or Vicious Culprit in COVID-19 Pathogenesis? Int. J. Infect. Dis. 2020;97:303&#x2013;305. doi: 10.1016/j.ijid.2020.05.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.110</ArticleId><ArticleId IdType="pmc">PMC7264936</ArticleId><ArticleId IdType="pubmed">32497811</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi A., Troiani E., Corrao S. COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review. Clin. Pract. 2020;10:24&#x2013;30. doi: 10.4081/cp.2020.1271.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippchen T., Altamura S., Muckenthaler M.U., Merle U. Hypoferremia Is Associated with Increased Hospitalization and Oxygen Demand in COVID-19 Patients. HemaSphere. 2020;4:e492. doi: 10.1097/HS9.0000000000000492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HS9.0000000000000492</ArticleId><ArticleId IdType="pmc">PMC7665253</ArticleId><ArticleId IdType="pubmed">33205000</ArticleId></ArticleIdList></Reference><Reference><Citation>Roeser H.P., Lee G.R., Nacht S., Cartwright G.E. The Role of Ceruloplasmin in Iron Metabolism. J. Clin. Investig. 1970;49:2408&#x2013;2417. doi: 10.1172/JCI106460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI106460</ArticleId><ArticleId IdType="pmc">PMC322742</ArticleId><ArticleId IdType="pubmed">5480864</ArticleId></ArticleIdList></Reference><Reference><Citation>Granick S. Ferritin: Its Properties and Significance for Iron Metabolism. Chem. Rev. 1945;38:379&#x2013;403. doi: 10.1021/cr60121a001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr60121a001</ArticleId><ArticleId IdType="pubmed">20992429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatucci A., Vachette P., Vasilyev V.B., Beltramini M., Sokolov A., Pulina M., Salvato B., Angelucci C.B., Maccarrone M., Cozzani I., et al. Structural Characterization of the Ceruloplasmin: Lactoferrin Complex in Solution. J. Mol. Biol. 2007;371:1038&#x2013;1046. doi: 10.1016/j.jmb.2007.05.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.05.089</ArticleId><ArticleId IdType="pubmed">17597152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta Y., Maciorowski D., Medernach B., Becker D.P., Durvasula R., Libertin C.R., Kempaiah P. Iron Dysregulation in COVID-19 and Reciprocal Evolution of SARS-CoV-2: Natura Nihil Frustra Facit. J. Cell. Biochem. 2022;123:601&#x2013;619. doi: 10.1002/jcb.30207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30207</ArticleId><ArticleId IdType="pmc">PMC9015563</ArticleId><ArticleId IdType="pubmed">34997606</ArticleId></ArticleIdList></Reference><Reference><Citation>Eid R., Arab N.T.T., Greenwood M.T. Iron Mediated Toxicity and Programmed Cell Death: A Review and a Re-Examination of Existing Paradigms. Biochim. Biophys. Acta Mol. Cell Res. 2017;1864:399&#x2013;430. doi: 10.1016/j.bbamcr.2016.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2016.12.002</ArticleId><ArticleId IdType="pubmed">27939167</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterbourn C.C. Toxicity of Iron and Hydrogen Peroxide: The Fenton Reaction. Toxicol. Lett. 1995;82&#x2013;83:969&#x2013;974. doi: 10.1016/0378-4274(95)03532-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-4274(95)03532-X</ArticleId><ArticleId IdType="pubmed">8597169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrer J.P. The Haber-Weiss Reaction and Mechanisms of Toxicity. Toxicology. 2000;149:43&#x2013;50. doi: 10.1016/S0300-483X(00)00231-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-483X(00)00231-6</ArticleId><ArticleId IdType="pubmed">10963860</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xu Y., Zhang K., Shen L., Deng M. Ferroptosis in COVID-19-Related Liver Injury: A Potential Mechanism and Therapeutic Target. Front. Cell. Infect. Microbiol. 2022;12:922511. doi: 10.3389/fcimb.2022.922511.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922511</ArticleId><ArticleId IdType="pmc">PMC9363633</ArticleId><ArticleId IdType="pubmed">35967872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarian G., Quinquenel A., Bellal M., Siavellis J., Jacquy C., Re D., Merabet F., Mekinian A., Braun T., Damaj G., et al. Autoimmune Haemolytic Anaemia Associated with COVID-19 Infection. Br. J. Haematol. 2020;190:29&#x2013;31. doi: 10.1111/bjh.16794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16794</ArticleId><ArticleId IdType="pmc">PMC7267601</ArticleId><ArticleId IdType="pubmed">32374906</ArticleId></ArticleIdList></Reference><Reference><Citation>Gadotti A.C., Lipinski A.L., Vasconcellos F.T., Marqueze L.F., Cunha E.B., Campos A.C., Oliveira C.F., Amaral A.N., Baena C.P., Telles J.P., et al. Susceptibility of the Patients Infected with SARS-CoV2 to Oxidative Stress and Possible Interplay with Severity of the Disease. Free Radic. Biol. Med. 2021;165:184&#x2013;190. doi: 10.1016/j.freeradbiomed.2021.01.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2021.01.044</ArticleId><ArticleId IdType="pmc">PMC7846460</ArticleId><ArticleId IdType="pubmed">33524532</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari N.R., Redewad N.K., Ketkar A.A., Sharma V.R. Elevated Plasma Hemoglobin in COVID-19&#x2013;Related Illnesses: A Critical Appraisal. Ann. Hematol. 2021;100:2125&#x2013;2126. doi: 10.1007/s00277-020-04281-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04281-2</ArticleId><ArticleId IdType="pmc">PMC7515552</ArticleId><ArticleId IdType="pubmed">32974839</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E., Ntanasis-Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T.N., Politou M., Psaltopoulou T., Gerotziafas G., Dimopoulos M.A. Hematological Findings and Complications of COVID-19. Am. J. Hematol. 2020;95:834&#x2013;847. doi: 10.1002/ajh.25829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25829</ArticleId><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S., Ahmad I., Lam A., Carlisle M.A., Li C., Wells J.M., Raju S.V., Athar M., Rowe S.M., Dransfield M.T., et al. Heme Scavenging Reduces Pulmonary Endoplasmic Reticulum Stress, Fibrosis, and Emphysema. JCI Insight. 2018;3:e120694. doi: 10.1172/jci.insight.120694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.120694</ArticleId><ArticleId IdType="pmc">PMC6238745</ArticleId><ArticleId IdType="pubmed">30385726</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal S., Lam A., Bolisetty S., Carlisle M.A., Traylor A., Agarwal A., Matalon S. Heme Attenuation Ameliorates Irritant Gas Inhalation-Induced Acute Lung Injury. Antioxidants Redox Signal. 2016;24:99&#x2013;112. doi: 10.1089/ars.2015.6347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2015.6347</ArticleId><ArticleId IdType="pmc">PMC4742996</ArticleId><ArticleId IdType="pubmed">26376667</ArticleId></ArticleIdList></Reference><Reference><Citation>Poggi C., Dani C. Antioxidant Strategies and Respiratory Disease of the Preterm Newborn: An Update. Oxid. Med. Cell. Longev. 2014;2014:721043. doi: 10.1155/2014/721043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/721043</ArticleId><ArticleId IdType="pmc">PMC3996983</ArticleId><ArticleId IdType="pubmed">24803984</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Fern&#xe1;ndez M., Aller R., Heredia-Rodr&#xed;guez M., G&#xf3;mez-S&#xe1;nchez E., Mart&#xed;nez-Paz P., Gonzalo-Benito H., S&#xe1;nchez-de Prada L., Gorgojo &#xd3;., Carnicero-Frutos I., Tamayo E., et al. Lipid Peroxidation as a Hallmark of Severity in COVID-19 Patients. Redox Biol. 2021;48:102181&#x2013;102188. doi: 10.1016/j.redox.2021.102181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102181</ArticleId><ArticleId IdType="pmc">PMC8572041</ArticleId><ArticleId IdType="pubmed">34768063</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehri F., Rahbar A.H., Ghane E.T., Souri B., Esfahani M. Changes in Oxidative Markers in COVID-19 Patients. Arch. Med. Res. 2021;52:843&#x2013;849. doi: 10.1016/j.arcmed.2021.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.06.004</ArticleId><ArticleId IdType="pmc">PMC8180845</ArticleId><ArticleId IdType="pubmed">34154831</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamagawa K., Taooka Y., Maeda A., Hiyama K., Ishioka S., Yamakido M. Inhibitory Effects of a Lecithinized Superoxide Dismutase on Bleomycin- Induced Pulmonary Fibrosis in Mice. Am. J. Respir. Crit. Care Med. 2000;161:1279&#x2013;1284. doi: 10.1164/ajrccm.161.4.9906099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.4.9906099</ArticleId><ArticleId IdType="pubmed">10764324</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K.I., Ishihara T., Azuma A., Kudoh S., Ebina M., Nukiwa T., Sugiyama Y., Tasaka Y., Namba T., Ishihara T., et al. Therapeutic Effect of Lecithinized Superoxide Dismutase on Bleomycin-Induced Pulmonary Fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010;298:348&#x2013;360. doi: 10.1152/ajplung.00289.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00289.2009</ArticleId><ArticleId IdType="pubmed">20034962</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka K.I., Tamura F., Sugizaki T., Kawahara M., Kuba K., Imai Y., Mizushima T. Evaluation of Lecithinized Superoxide Dismutase for the Prevention of Acute Respiratory Distress Syndrome in Animal Models. Am. J. Respir. Cell Mol. Biol. 2017;56:179&#x2013;190. doi: 10.1165/rcmb.2016-0158OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2016-0158OC</ArticleId><ArticleId IdType="pubmed">27668315</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghoubi N., Youssefi M., Jabbari Azad F., Farzad F., Yavari Z., Zahedi Avval F. Total Antioxidant Capacity as a Marker of Severity of COVID-19 Infection: Possible Prognostic and Therapeutic Clinical Application. J. Med. Virol. 2022;94:1558&#x2013;1565. doi: 10.1002/jmv.27500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27500</ArticleId><ArticleId IdType="pmc">PMC9015601</ArticleId><ArticleId IdType="pubmed">34862613</ArticleId></ArticleIdList></Reference><Reference><Citation>Abouhashem A.S., Singh K., Azzazy H.M.E., Sen C.K. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19? Antioxidants Redox Signal. 2020;33:59&#x2013;65. doi: 10.1089/ars.2020.8111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2020.8111</ArticleId><ArticleId IdType="pmc">PMC7307702</ArticleId><ArticleId IdType="pubmed">32323565</ArticleId></ArticleIdList></Reference><Reference><Citation>Keles E.S. Mild SARS-CoV-2 Infections in Children Might Be Based on Evolutionary Biology and Linked with Host Reactive Oxidative Stress and Antioxidant Capabilities. New Microbes New Infect. 2020;36:100723. doi: 10.1016/j.nmni.2020.100723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmni.2020.100723</ArticleId><ArticleId IdType="pmc">PMC7313508</ArticleId><ArticleId IdType="pubmed">32670592</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M. An Intriguing and Hitherto Unexplained Co-Occurrence: Depression and Chronic Fatigue Syndrome Are Manifestations of Shared Inflammatory, Oxidative and Nitrosative (IO&amp;NS) Pathways. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2011;35:784&#x2013;794. doi: 10.1016/j.pnpbp.2010.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.06.023</ArticleId><ArticleId IdType="pubmed">20609377</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T., Zhong S., Liao X., Chen J., He T., Lai S., Jia Y. A Meta-Analysis of Oxidative Stress Markers in Depression. PLoS ONE. 2015;10:e0138904. doi: 10.1371/journal.pone.0138904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138904</ArticleId><ArticleId IdType="pmc">PMC4596519</ArticleId><ArticleId IdType="pubmed">26445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Rachayon M., Jirakran K., Sodsai P., Klinchanhom S., Ga&#x142;ecki P., Sughondhabirom A., Basta-Kaim A. The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach. Cells. 2022;11:1183. doi: 10.3390/cells11071183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071183</ArticleId><ArticleId IdType="pmc">PMC8997660</ArticleId><ArticleId IdType="pubmed">35406747</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID Post-Viral Chronic Fatigue Syndrome and Affective Symptoms Are Associated with Oxidative Damage, Lowered Antioxidant Defenses and Inflammation: A Proof of Concept and Mechanism Study. Mol Psychiatry. 2022;24:1&#x2013;15. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox Imbalance Links COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox P.L., Mazumder B., Ehrenwald E., Mukhopadhyay C.K. Ceruloplasmin and Cardiovascular Disease. Free Radic. Biol. Med. 2000;28:1735&#x2013;1744. doi: 10.1016/S0891-5849(00)00231-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00231-8</ArticleId><ArticleId IdType="pubmed">10946215</ArticleId></ArticleIdList></Reference><Reference><Citation>Lage S.L., Amaral E.P., Hilligan K.L., Laidlaw E., Rupert A., Namasivayan S., Rocco J., Galindo F., Kellogg A., Kumar P., et al. Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16&#x2212; Monocytes From COVID-19 Patients. Front. Immunol. 2022;12:799558. doi: 10.3389/fimmu.2021.799558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.799558</ArticleId><ArticleId IdType="pmc">PMC8795739</ArticleId><ArticleId IdType="pubmed">35095880</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharmacol. 2022;13:e2024358118. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Menshawey R., Menshawey E., Alserr A.H.K., Abdelmassih A.F. Low Iron Mitigates Viral Survival: Insights from Evolution, Genetics, and Pandemics&#x2014;A Review of Current Hypothesis. Egypt. J. Med. Hum. Genet. 2020;21:2&#x2013;14. doi: 10.1186/s43042-020-00114-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43042-020-00114-z</ArticleId><ArticleId IdType="pmc">PMC7738201</ArticleId><ArticleId IdType="pubmed">38624521</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.C., Bayeva M., Taiwo B., Palella F.J., Hope T.J., Ardehali H. Short Communication: High Cellular Iron Levels Are Associated with Increased HIV Infection and Replication. AIDS Res. Hum. Retroviruses. 2015;31:305&#x2013;312. doi: 10.1089/aid.2014.0169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2014.0169</ArticleId><ArticleId IdType="pmc">PMC4348083</ArticleId><ArticleId IdType="pubmed">25291189</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinsella M., Monk C. Evaluation of Iron Deficiency As a Nutritional Adaptation to Infectious Disease: An Evolutionary Medicine Perspective. Am. J. Hum. Biol. 2012;23:172&#x2013;179. doi: 10.1002/ajhb.20839.Evaluation.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajhb.20839.Evaluation</ArticleId><ArticleId IdType="pmc">PMC3938201</ArticleId><ArticleId IdType="pubmed">18949769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakurkar V., Rajapurkar M., Lele S., Mukhopadhyay B., Lobo V., Injarapu R., Sheikh M., Dholu B., Ghosh A., Jha V. Increased Serum Catalytic Iron May Mediate Tissue Injury and Death in Patients with COVID-19. Sci. Rep. 2021;11:19618. doi: 10.1038/s41598-021-99142-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99142-x</ArticleId><ArticleId IdType="pmc">PMC8490366</ArticleId><ArticleId IdType="pubmed">34608227</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohus R.M., Flatby H., Liyanarachi K.V., DeWan A.T., Sollig&#xe5;rd E., Dam&#xe5;s J.K., &#xc5;svold B.O., Gustad L.T., Rogne&#xa0; T. Iron Status and the Risk of Sepsis and Severe COVID-19: A Two-Sample Mendelian Randomization Study. Sci. Rep. 2022;12:16157. doi: 10.1038/s41598-022-20679-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-20679-6</ArticleId><ArticleId IdType="pmc">PMC9516524</ArticleId><ArticleId IdType="pubmed">36171422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanauske-Abel H.M., Saxena D., Palumbo P.E., Hanauske A.R., Luchessi A.D., Cambiaghi T.D., Hoque M., Spino M., Gandolfi D.D.A., Heller D.S., et al. Drug-Induced Reactivation of Apoptosis Abrogates HIV-1 Infection. PLoS ONE. 2013;8:e74414. doi: 10.1371/journal.pone.0074414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0074414</ArticleId><ArticleId IdType="pmc">PMC3781084</ArticleId><ArticleId IdType="pubmed">24086341</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhabra R., Saha A., Chamani A., Schneider N., Nanjundan M., Shah R. Iron pathways and iron chelation approaches in viral, microbial, and fungal infections. Pharmaceuticals. 2020;13:275. doi: 10.3390/ph13100275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph13100275</ArticleId><ArticleId IdType="pmc">PMC7601909</ArticleId><ArticleId IdType="pubmed">32992923</ArticleId></ArticleIdList></Reference><Reference><Citation>Abobaker A. Reply: Iron Chelation May Harm Patients with COVID-19. Eur. J. Clin. Pharmacol. 2021;77:267&#x2013;268. doi: 10.1007/s00228-020-02988-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-020-02988-9</ArticleId><ArticleId IdType="pmc">PMC7459945</ArticleId><ArticleId IdType="pubmed">32870381</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonyek-Silva I., Machado A.F.A., Cerqueira-Silva T., Nunes S., Cruz M.R.S., Silva J., Santos R.L., Barral A., Oliveira P.R.S., Khouri R., et al. LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 during Severe COVID-19 in Individuals with Diabetes. Diabetes. 2021;70:2120&#x2013;2130. doi: 10.2337/db20-1260.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db20-1260</ArticleId><ArticleId IdType="pmc">PMC8576416</ArticleId><ArticleId IdType="pubmed">34417262</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas B., Paul-Eugene N., Cairns J., Gordon J., Calenda A., Mencia-Huerta J.M., Braquet P. LeukotrieneB4 Potentiates the Expression and Release of FceRII/CD23, and Proliferation and Differentiation of Human B Lymphocytes Induced by IL-4. J. Immunol. 1990;145:3406&#x2013;3411.</Citation><ArticleIdList><ArticleId IdType="pubmed">2172383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone A.M., Task&#xe9;n K. Proinflammatory and Immunoregulatory Roles of Eicosanoids in T Cells. Front. Immunol. 2013;4:00130. doi: 10.3389/fimmu.2013.00130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00130</ArticleId><ArticleId IdType="pmc">PMC3671288</ArticleId><ArticleId IdType="pubmed">23760108</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanbroek R., Hildner M., K&#xf6;hler A., M&#xfc;ller A., Zintl F., K&#xfc;hn H., R&#xe5;dmark O., Samuelsson B., Habenicht A.J.R. IL-4 Determines Eicosanoid Formation in Dendritic Cells by down-Regulation of 5-Lipoxygenase and up-Regulation of 15-Lipoxygenase 1 Expression. Proc. Natl. Acad. Sci. USA. 2001;98:5152&#x2013;5157. doi: 10.1073/pnas.091076998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.091076998</ArticleId><ArticleId IdType="pmc">PMC33179</ArticleId><ArticleId IdType="pubmed">11320251</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Paula C.B., de Azevedo M.L.V., Nagashima S., Martins A.P.C., Malaquias M.A.S., Miggiolaro A.F.R.d.S., da Silva Motta J&#xfa;nior J., Avelino G., do Carmo L.A.P., Carstens L.B., et al. IL-4/IL-13 Remodeling Pathway of COVID-19 Lung Injury. Sci. Rep. 2020;10:4&#x2013;11. doi: 10.1038/s41598-020-75659-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75659-5</ArticleId><ArticleId IdType="pmc">PMC7596721</ArticleId><ArticleId IdType="pubmed">33122784</ArticleId></ArticleIdList></Reference><Reference><Citation>Afonso P.V., Janka-Junttila M., Lee Y.J., McCann C.P., Oliver C.M., Aamer K.A., Losert W., Cicerone M.T., Parent C.A. LTB4 Is a Signal-Relay Molecule during Neutrophil Chemotaxis. Dev. Cell. 2012;22:1079&#x2013;1091. doi: 10.1016/j.devcel.2012.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2012.02.003</ArticleId><ArticleId IdType="pmc">PMC4141281</ArticleId><ArticleId IdType="pubmed">22542839</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk C.D., Ardakani A. A Novel Strategy to Mitigate the Hyperin Fl Ammatory Response to COVID-19 by Targeting Leukotrienes. Front. Pharmacol. 2020;11:01214. doi: 10.3389/fphar.2020.01214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01214</ArticleId><ArticleId IdType="pmc">PMC7424064</ArticleId><ArticleId IdType="pubmed">32848802</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyahara N., Miyahara S., Takeda K., Gelfand E.W. Role of the LTB4/BLT1 Pathway in Allergen-Induced Airway Hyperresponsiveness and Inflammation. Allergol. Int. 2006;55:91&#x2013;97. doi: 10.2332/allergolint.55.91.</Citation><ArticleIdList><ArticleId IdType="doi">10.2332/allergolint.55.91</ArticleId><ArticleId IdType="pubmed">17075244</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bel M., Brunet A., Gosselin J. Leukotriene B4, an Endogenous Stimulator of the Innate Immune Response against Pathogens. J. Innate Immun. 2014;6:159&#x2013;168. doi: 10.1159/000353694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000353694</ArticleId><ArticleId IdType="pmc">PMC6741447</ArticleId><ArticleId IdType="pubmed">23988515</ArticleId></ArticleIdList></Reference><Reference><Citation>Widegren H., Andersson M., Borgeat P., Flamand L., Johnston S., Greiff L. LTB4 Increases Nasal Neutrophil Activity and Conditions Neutrophils to Exert Antiviral Effects. Respir. Med. 2011;105:997&#x2013;1006. doi: 10.1016/j.rmed.2010.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2010.12.021</ArticleId><ArticleId IdType="pmc">PMC7127613</ArticleId><ArticleId IdType="pubmed">21251805</ArticleId></ArticleIdList></Reference><Reference><Citation>He R., Chen Y., Cai Q. The Role of the LTB4-BLT1 Axis in Health and Disease. Pharmacol. Res. 2020;158:104857. doi: 10.1016/j.phrs.2020.104857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104857</ArticleId><ArticleId IdType="pubmed">32439596</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt S.L., Wang S., Dejani N.N., Klopfenstein N., Winfree S., Filgueiras L., McCarthy B.P., Territo P.R., Serezani C.H. Excessive Localized Leukotriene B4 Levels Dictate Poor Skin Host Defense in Diabetic Mice. JCI Insight. 2018;3:e120220. doi: 10.1172/jci.insight.120220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.120220</ArticleId><ArticleId IdType="pmc">PMC6171805</ArticleId><ArticleId IdType="pubmed">30185672</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao A., Wong F., Ayala J.M., Struthers M., Ujjainwalla F., Wright S.D., Springer M.S., Evans J., Cui J. Leukotriene B4 Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes. Arterioscler. Thromb. Vasc. Biol. 2004;24:1783&#x2013;1788. doi: 10.1161/01.ATV.0000140063.06341.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000140063.06341.09</ArticleId><ArticleId IdType="pubmed">15271789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki F., Yokomizo T. The Leukotriene Receptors as Therapeutic Targets of Inflammatory Diseases. Int. Immunol. 2019;31:607&#x2013;615. doi: 10.1093/intimm/dxz044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxz044</ArticleId><ArticleId IdType="pubmed">31135881</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Lam B.K., Kanaoka Y., Nigrovic P.A., Audoly L.P., Austen K.F., Lee D.M. Neutrophil-Derived Leukotriene B4 Is Required for Inflammatory Arthritis. J. Exp. Med. 2006;203:837&#x2013;842. doi: 10.1084/jem.20052371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20052371</ArticleId><ArticleId IdType="pmc">PMC2118292</ArticleId><ArticleId IdType="pubmed">16567388</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Clemente M., Cl&#xe0;ria J., Titos E. The 5-Lipoxygenase/Leukotriene Pathway in Obesity, Insulin Resistance, and Fatty Liver Disease. Curr. Opin. Clin. Nutr. Metab. Care. 2011;14:347&#x2013;353. doi: 10.1097/MCO.0b013e32834777fa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0b013e32834777fa</ArticleId><ArticleId IdType="pubmed">21587068</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M., Artime A., Pariente E., Fierro P., Ruiz Y., Guti&#xe9;rrez S., Tobalina M., D&#xed;az-Salazar S., Ramos C., Olmos J.M., et al. Post-COVID-19 Syndrome, Low-Grade Inflammation and Inflammatory Markers: A Cross-Sectional Study. Curr. Med. Res. Opin. 2022;38:901&#x2013;909. doi: 10.1080/03007995.2022.2042991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman D., Campisi J., Verdin E., Carrera-Bastos P., Targ S., Franceschi C., Ferrucci L., Gilroy D.W., Fasano A., Miller G.W., et al. Chronic Inflammation in the Etiology of Disease across the Life Span. Nat. Med. 2019;25:1822&#x2013;1832. doi: 10.1038/s41591-019-0675-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0675-0</ArticleId><ArticleId IdType="pmc">PMC7147972</ArticleId><ArticleId IdType="pubmed">31806905</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S., Hartung F., Henkel F., Quaranta A., Kolmert J., Priller A., Ud-dean M. Mild COVID-19 Imprints a Long-Term in Fl Ammatory Eicosanoid- and Chemokine Memory in Monocyte-Derived Macrophages. Mucosal Immunol. 2022;15:515&#x2013;524. doi: 10.1038/s41385-021-00482-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent That Interferes with Siderophore-Mediated Iron Acquisition. Mol. Cell. 2002;10:1033&#x2013;1043. doi: 10.1016/S1097-2765(02)00708-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(02)00708-6</ArticleId><ArticleId IdType="pubmed">12453412</ArticleId></ArticleIdList></Reference><Reference><Citation>Flo T., Smith K.D., Sato S., David R.J., Holmes M., Strong R.K., Aderem A. Lipocalin 2 Mediates an Innate Immune Response to Bacterial Infection by Sequestering Iron. Nature. 2004;432:913&#x2013;917. doi: 10.1038/nature03104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03104</ArticleId><ArticleId IdType="pubmed">15531878</ArticleId></ArticleIdList></Reference><Reference><Citation>Akg&#xfc;l B., Bauer B., Zigrino P., Storey A., Mauch C., Pfister H. Upregulation of Lipocalin-2 in Human Papillomavirus-Positive Keratinocytes and Cutaneous Squamous Cell Carcinomas. J. Gen. Virol. 2011;92:395&#x2013;401. doi: 10.1099/vir.0.025064-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.025064-0</ArticleId><ArticleId IdType="pubmed">21048034</ArticleId></ArticleIdList></Reference><Reference><Citation>No&#xe7;on A.L., Ip J.P.K., Terry R., Lim S.L., Getts D.R., M&#xfc;ller M., Hofer M.J., King N.J.C., Campbell I.L. The Bacteriostatic Protein Lipocalin 2 Is Induced in the Central Nervous System of Mice with West Nile Virus Encephalitis. J. Virol. 2014;88:679&#x2013;689. doi: 10.1128/JVI.02094-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02094-13</ArticleId><ArticleId IdType="pmc">PMC3911733</ArticleId><ArticleId IdType="pubmed">24173226</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Jaberi S., Cohen A., D&#x2019;Souza C., Abdulrazzaq Y.M., Ojha S., Bastaki S., Adeghate E.A. Lipocalin-2: Structure, Function, Distribution and Role in Metabolic Disorders. Biomed. Pharmacother. 2021;142:112002. doi: 10.1016/j.biopha.2021.112002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112002</ArticleId><ArticleId IdType="pubmed">34463264</ArticleId></ArticleIdList></Reference><Reference><Citation>Flower D.R., North A.C.T., Sansom C.E. The Lipocalin Protein Family: Structural and Sequence Overview. Biochim. Biophys. Acta-Protein Struct. Mol. Enzymol. 2000;1482:9&#x2013;24. doi: 10.1016/S0167-4838(00)00148-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4838(00)00148-5</ArticleId><ArticleId IdType="pubmed">11058743</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasshauer M., Blu M. Adipokines in Health and Disease. Rev. Trends Pharmacol. Sci. 2015;36:461&#x2013;470. doi: 10.1016/j.tips.2015.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.04.014</ArticleId><ArticleId IdType="pubmed">26022934</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinstein T., Pitashny M., Putterman C. The Novel Role of Neutrophil Gelatinase-B Associated Lipocalin (NGAL)/Lipocalin-2 as a Biomarker for Lupus Nephritis. Autoimmun. Rev. 2008;7:229&#x2013;234. doi: 10.1016/j.autrev.2007.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2007.11.013</ArticleId><ArticleId IdType="pubmed">18190883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mike E.V., Makinde H.M., Gulinello M., Vanarsa K., Herlitz L., Gadhvi G., Winter D.R., Mohan C., Hanly J.G., Mok C.C., et al. Lipocalin-2 Is a Pathogenic Determinant and Biomarker of Neuropsychiatric Lupus. J. Autoimmun. 2019;96:59&#x2013;73. doi: 10.1016/j.jaut.2018.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.08.005</ArticleId><ArticleId IdType="pmc">PMC6310639</ArticleId><ArticleId IdType="pubmed">30174216</ArticleId></ArticleIdList></Reference><Reference><Citation>Warszawska J.M., Gawish R., Sharif O., Sigel S., Doninger B., Lakovits K., Mesteri I., Nairz M., Boon L., Spiel A., et al. Lipocalin 2 Deactivates Macrophages and Worsens Pneumococcal Pneumonia Outcomes. J. Clin. Investig. 2013;123:3363&#x2013;3372. doi: 10.1172/JCI67911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI67911</ArticleId><ArticleId IdType="pmc">PMC3726165</ArticleId><ArticleId IdType="pubmed">23863624</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Li S., Tang X., Liang L., Wang F., Du H. Lipocalin 2 Protects Against Escherichia Coli Infection by Modulating Neutrophil and Macrophage Function. Front. Immunol. 2019;10:02594. doi: 10.3389/fimmu.2019.02594.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02594</ArticleId><ArticleId IdType="pmc">PMC6857527</ArticleId><ArticleId IdType="pubmed">31781104</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu L., Hittelman W., Lu T., Ji P., Arlinghaus R., Shmulevich I., Hamilton S.R., Zhang W. NGAL Decreases E-Cadherin-Mediated Cellcell Adhesion and Increases Cell Motility and Invasion through Rac1 in Colon Carcinoma Cells. Lab. Investig. 2009;89:531&#x2013;548. doi: 10.1038/labinvest.2009.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2009.17</ArticleId><ArticleId IdType="pmc">PMC7770608</ArticleId><ArticleId IdType="pubmed">19308044</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X., Yeoh B.S., Saha P., Olvera R.A., Singh V., Vijay-Kumar M. Lipocalin 2 Alleviates Iron Toxicity by Facilitating Hypoferremia of Inflammation and Limiting Catalytic Iron Generation. BioMetals. 2016;29:451&#x2013;465. doi: 10.1007/s10534-016-9925-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-016-9925-5</ArticleId><ArticleId IdType="pmc">PMC4880510</ArticleId><ArticleId IdType="pubmed">27007712</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao G., Clifton M., Hoette T.M., Mori K., Deng S., Qiu A., Viltard M., Williams D., Paragas N., Leete T., et al. Iron Traffics in Circulation Bound to a Siderocalin (Ngal)- Catechol Complex. Nat Chem Biol. 2010;6:602&#x2013;609. doi: 10.1038/nchembio.402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.402</ArticleId><ArticleId IdType="pmc">PMC2907470</ArticleId><ArticleId IdType="pubmed">20581821</ArticleId></ArticleIdList></Reference><Reference><Citation>Barasch J., Hollmen M., Deng R., Hod E.A., Rupert P.B., Abergel R.J., Allred B.E., Xu K., Darrah S.F., Tekabe Y., et al. Disposal of Iron by a Mutant Form of Lipocalin 2. Nat. Commun. 2016;7:12973. doi: 10.1038/ncomms12973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12973</ArticleId><ArticleId IdType="pmc">PMC5095531</ArticleId><ArticleId IdType="pubmed">27796299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao G., Road C., Xu J., Road C., Hu F., Wan X., Road C., Deng S., Barasch J. EGCG Inhibit Chemical Reactivity of Iron through Forming an Ngal&#x2013;EGCG&#x2013;Iron Complex. Biometals. 2015;26:1041&#x2013;1050. doi: 10.1007/s10534-013-9681-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-013-9681-8</ArticleId><ArticleId IdType="pmc">PMC4416964</ArticleId><ArticleId IdType="pubmed">24158698</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Liu X., Meng L., Liu S., Wang L., Li J., Cui C., Meng J., Hu S., Wei Y. Up-Regulated Lipocalin-2 in Pulmonary Hypertension Involving in Pulmonary Artery SMC Resistance to Apoptosis. Int. J. Biol. Sci. 2014;10:798&#x2013;806. doi: 10.7150/ijbs.9470.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.9470</ArticleId><ArticleId IdType="pmc">PMC4115200</ArticleId><ArticleId IdType="pubmed">25076856</ArticleId></ArticleIdList></Reference><Reference><Citation>Halabian R., Tehrani H.A., Jahanian-Najafabadi A., Habibi Roudkenar M. Lipocalin-2-Mediated Upregulation of Various Antioxidants and Growth Factors Protects Bone Marrow-Derived Mesenchymal Stem Cells against Unfavorable Microenvironments. Cell Stress Chaperones. 2013;18:785&#x2013;800. doi: 10.1007/s12192-013-0430-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-013-0430-2</ArticleId><ArticleId IdType="pmc">PMC3789877</ArticleId><ArticleId IdType="pubmed">23620204</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and Why Patients Made Long COVID. Soc. Sci. Med. 2021;268:2&#x2013;5. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchisio M., Simeone P., Bologna G., Ercolino E., Pierdomenico L., Pieragostino D., Ventrella A., Antonini F., Del Zotto G., Vergara D., et al. Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood Samples. Int. J. Mol. Sci. 2021;22:48. doi: 10.3390/ijms22010048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010048</ArticleId><ArticleId IdType="pmc">PMC7793062</ArticleId><ArticleId IdType="pubmed">33374539</ArticleId></ArticleIdList></Reference><Reference><Citation>Cela I., Cufaro M.C., Fucito M., Pieragostino D., Lanuti P., Sallese M., Del Boccio P., Di Matteo A., Allocati N., De Laurenzi V., et al. Proteomic Investigation of the Role of Nucleostemin in Nucleophosmin-Mutated OCI-AML 3 Cell Line. Int. J. Mol. Sci. 2022;23:7655. doi: 10.3390/ijms23147655.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23147655</ArticleId><ArticleId IdType="pmc">PMC9317519</ArticleId><ArticleId IdType="pubmed">35886999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufrusine B., Damiani V., Capone E., Pieragostino D., Dainese E., De Marco M., Reppucci F., Turco M.C., Rosati A., Marzullo L., et al. BAG3 Induces Fibroblasts to Release Key Cytokines Involved in Pancreatic Cell Migration. J. Cell. Biochem. 2022;123:65&#x2013;76. doi: 10.1002/jcb.30172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.30172</ArticleId><ArticleId IdType="pmc">PMC9297949</ArticleId><ArticleId IdType="pubmed">34741485</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>